Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority TrialVanita Noronha, Kumar Prabhash, Prathamesh Pai et al.|Journal of Clinical Oncology|2017Cited by 340
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancerVijay Patil, Manish Pandey, Vanita Noronha et al.|Cancer|2019Cited by 133
SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational studySachin Dhumal, Sudeep Gupta, Amar Patil et al.|International Journal of Infectious Diseases|2022Cited by 29
Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapyVedang Murthy, Rahul Krishnatry, Ganesh Bakshi et al.|Urologic Oncology Seminars and Original Investigations|2021Cited by 20
Results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.Vijay Patil, Kumar Prabhash, Vanita Noronha et al.|Journal of Clinical Oncology|2018Cited by 11